The Claim
Methylene blue and 3-[4-(trifluoromethyl)benzyl]-menadione do not inhibit the mitochondrial electron transport chain in Plasmodium falciparum parasites in vitro, as evidenced by no reduction in parasite viability, in contrast to atovaquone, indicating their antimalarial mechanism involves an alternative redox-based pathway with subversive electron shuttling.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Two chemicals, methylene blue and another compound, don’t stop malaria parasites from using their energy system the way a known drug (atovaquone) does — so they must be killing the parasites in a completely different way, probably by messing with how electrons move inside the cell.
See the scientific wording
Methylene blue and 3-[4-(trifluoromethyl)benzyl]-menadione do not inhibit the mitochondrial electron transport chain in Plasmodium falciparum parasites in vitro, as demonstrated by lack of effect on parasite viability compared to atovaquone, a known mitochondrial inhibitor, suggesting their antimalarial action occurs through an alternative redox-based mechanism involving subversive electron shuttling.
What the research says
1 studyThis study shows that methylene blue and the related chemical kill malaria parasites not by messing with their energy factories (mitochondria), but by tricking them with fake electron signals that disrupt their digestion process.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.